Is reduction of blood pressure in acute stroke justified?

The Lancet Neurology

Volumn 10, Issue 4, 2011, Pages 295-296

  Gorelick, Philip B ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANDESARTAN;

BLOOD PRESSURE REGULATION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; HEART FAILURE; LETTER; PRACTICE GUIDELINE; PRIORITY JOURNAL; STROKE;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; HUMANS; HYPERTENSION; STROKE;

EID: 79952728162     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(11)70040-0     Document Type: Letter

References (7)

1. Aiyagari V, Gorelick PB Management of blood pressure for acute and recurrent stroke. Stroke 2009, 40:2251-2256.
2. Hankey GJ Lowering blood pressure in acute stroke: the SCAST trial. Lancet 2011, 371:696-698.
3. Sandset EC, Bath PMW, Boysen G, et al. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet 2011, 371:741-750. on behalf of the SCAST Study Group.
4. Adams HP, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Stroke 2007, 38:1655-1711.
5. Morgenstern LB, Hemphill JC, Anderson C Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2010, 41:2108-2129. on behalf of the American Heart Association Stroke Council and endorsed by the American Academy of Neurology, American Association of Neurological SurgeonsAmerican Association of Neurological Surgeons, the Congress of Neurological Surgeonsthe Congress of Neurological Surgeons.
6. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008, 25:457-507. The European Stroke Organisation (ESO) Executive Committee and ESO Writing Committee.
7. Yusuf S, Diener MC, Sacco RL, et al. for the PROFESS Study Group. Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med 2008, 359:1225-1237.